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ORIGINAL ARTICLE
A cooperative interaction between LPHN3 and 11q
doubles the risk for ADHD
M Jain1, JI Ve´lez1, MT Acosta1, LG Palacio2, J Balog1, E Roessler1, D Pineda2, AC London˜o2,
JD Palacio2, A Arbelaez2, F Lopera2, J Elia3, H Hakonarson3, C Seitz4, CM Freitag4, H Palmason5,
J Meyer5, M Romanos6, S Walitza6, U Hemminger6, A Warnke6, J Romanos7, T Renner6,7,8, C Jacob7,
K-P Lesch6,7,8, J Swanson9, FX Castellanos10, JE Bailey-Wilson1, M Arcos-Burgos1 and M Muenke1
1Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA;
2Neurosciences Group, University of Antioquia, Medellı´n, Colombia; 3The Children’s Hospital of Philadelphia, Philadelphia, PA,
USA; 4Department of Child and Adolescent Psychiatry, Saarland University Hospital, Homburg, Saar, Germany; 5Graduate
School for Psychobiology, Division of Neuro-Behavioral Genetics, University of Trier, Trier, Germany; 6Department of Child and
Adolescent Psychiatry and Psychotherapy, University of Wu¨rzburg, Wu¨rzburg, Germany; 7Department of Psychiatry and
Psychotherapy, University of Wu¨rzburg, Wu¨rzburg, Germany; 8Molecular and Psychobiology, University of Wu¨rzburg,
Wu¨rzburg, Germany; 9UCI Child Development Center, University of California, Irvine, CA, USA and 10New York University
Child Study Center, New York, NY, USA
In previous studies of a genetic isolate, we identified significant linkage of attention deficit
hyperactivity disorder (ADHD) to 4q, 5q, 8q, 11q and 17p. The existence of unique large size
families linked to multiple regions, and the fact that these families came from an isolated
population, we hypothesized that two-locus interaction contributions to ADHD were plausible.
Several analytical models converged to show significant interaction between 4q and 11q
(P<1 108) and 11q and 17p (P<1 106). As we have identified that common variants of the
LPHN3 gene were responsible for the 4q linkage signal, we focused on 4q–11q interaction to
determine that single-nucleotide polymorphisms (SNPs) harbored in the LPHN3 gene interact
with SNPs spanning the 11q region that contains DRD2 and NCAM1 genes, to double the risk
of developing ADHD. This interaction not only explains genetic effects much better than taking
each of these loci effects by separated but also differences in brain metabolism as depicted by
proton magnetic resonance spectroscopy data and pharmacogenetic response to stimulant
medication. These findings not only add information about how high order genetic interactions
might be implicated in conferring susceptibility to develop ADHD but also show that future
studies of the effects of genetic interactions on ADHD clinical information will help to shape
predictive models of individual outcome.
Molecular Psychiatry (2012) 17, 741–747; doi:10.1038/mp.2011.59; published online 24 May 2011
Keywords: ADHD; genetic interaction; LPHN3; NCAM1; DRD2
Introduction
Using multigenerational and extended pedigrees from
a genetic isolate our group identified several loci
significantly linked to attention deficit hyperactivity
disorder (ADHD), namely on 4q, 5q, 8q, 11q and 17p.1
Regions on 11q and 17p replicated linkage described
by others.2 Minimal critical regions for each one of
these regions, defined by recombination events in
affected individuals as well as the 1-LOD-support
criterion, have been reported elsewhere.1 Given the
significant linkage to different genomic regions, the
existence of unique large size families linked to
multiple regions, and the fact that these families
came from an isolated population, we hypothesized
that two-locus interaction contributions to ADHD
were plausible.
Methods and Results
To screen for possible interacting regions, we initially
performed a correlation subset analysis3 between the
linked regions. We used 134 nuclear families from
the Paisa genetic isolate and single-nucleotide poly-
morphisms (SNPs) spanning each minimal critical
region with a resolution of 200 kb (mapping resolu-
tion as well as SNPs selection criteria have been
published in detail elsewhere4). We calculated the
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non-parametric linkage (NPL) score using GENE-
HUNTER5 with the weight function weight10, where
families that demonstrated nominal NPL (NPL>1.00)
to a region were included in the analysis (that is, were
coded as 1 for weight10) and those families not
demonstrating linkage were excluded (that is, were
coded as 0 for weight10).
3 To measure heterogeneity
the weight function weight01 (defined analogously)
was used, where only those families that did not
demonstrate linkage to a region were included in the
analysis.3 Of the entire possible set of pair-wise
comparisons, two gave increases in the NPL statistic
greater than two units when compared with linkage
analyses using all families. Selecting families linked
to 17p increased the nonparametric linkage statistic
from 0.55 to 3.88 on 11q (17p–11q interaction) and
selecting families linked to 4q increased the NPL
statistic from 0.55 to 3.24 in an overlapping region on
11q (4q–11q interaction; Figure 1a, Supplementary
Information). Using the method implemented in
GENEHUNTER-TWOLOCUS,6,7 we found a maximal
non-parametric score of 6.08 (P<1108) produced
by SNPs rs1038426 (4q) and rs1293344 (11q; 4q–11q
interaction; Figure 1b, Supplementary Information)
and a maximal non-parametric score of 5.51
(P<1 106), produced by SNPs rs9227 (17p) and
rs1293344 (11q; 17p–11q interaction; Figure 1c,
Supplementary Information). Convergent evidence
of interaction was detected while using two-locus
parametric analysis. Furthermore, power analyses to
detect two interacting loci while considering ADHD
as a binary trait and also to detect interacting loci
underlying quantitative traits, shows that, in general,
our discovery sample exhibits exceptional power to
detect two-locus interactions (see procedures at-
tached to the Supplementary Information).
Using a very stringent linkage disequilibrium map
with a resolution of B68kb (two times stronger that
the resolution recommended for covering this geno-
mic area4) we also demonstrated that throughout the
scanned region there was a remarkable total absence
of linkage disequilibrium gaps, meaning that our
genotyped markers covered any variation inside of the
4q-linked region. With this map, we identified a
unique region of association and linkage of B240Kb.
None other areas inside of the 4q-linked region
showed positive association. The region of B240Kb
was harbored inside of the LPHN3 gene. Additional
analysis showed that LPHN3 common variant confers
susceptibility to ADHD affects brain metabolism and
predicts effectiveness of stimulant medication.4 We
showed that three markers harbored in LPHN3 passed
the test of heterogeneity and were significant after
adjusting for multiple tests: rs6551665 (odds ratio
(OR) = 1.23, 95% confidence interval (CI) 1.09–1.37,
P=3.46 104), rs1947274 (OR=1.23, 95% CI=1.09–
1.38, P=5.41104) and rs2345039 (OR=1.21, 95%
CI=1.08–1.35, P=8.97 104). The marker rs6551665
was genotyped in all the samples and showed
a linkage disequilibrium r2 with these other two
markers > 90%.
Given the demonstrated association of ADHD
susceptibility to rs6551665 (G, allele), a SNP harbored
inside the genomic region coding for LPHN3, we next
performed an association analysis using SNPs on 11q
and 17p and conditioning on the fact of being a carrier
Figure 1 (a) Results of a case–control association analysis, in which one individual was selected per family based on having
a susceptibility haplotype on 4q within LPHN3 (48 cases and 40 controls; circles) or irrespective of haplotype within LPHN3
(squares). The filled rectangles represent haplotypes made of the most significant markers. Results are plotted as the log
(P-value). The dashed line indicates significance as established by the Bonferroni correction (Pcorrected = 0.01/139= 0.000072).
A single haplotype, rs677642-rs877137, is very significant in this analysis (P<0.000005; GG; 57% allele frequency cases;
23% allele frequency controls). A diagram of the region encompassed by the haplotype as depicted at the University of
California, Santa Cruz genome browser is presented. (b) This figure presents the meta-analysis results for the four samples
included in the study for a random effects model P<0.00001, OR=2.46 (95% 1.68–3.70).
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of the G variant of susceptibility at rs6551665. Either
one case or control with at least one copy of the
rs6551665 LPHN3 susceptibility G variant was se-
lected per family. Because of the rareness of indivi-
duals homozygous for the rs6551665 G allele we
pooled them with G heterozygotes, when we condi-
tioned on the fact of being a carrier of the G variant of
susceptibility at rs6551665, we were able to narrow
down signals at 11q and 17p. However, the signal at
11q pointed to a region containing only three genes,
whereas the signal at 17p spanned a genomic region
containing dozens of genes. Furthermore, given that
testing three-locus interactions (LPHN3–11q–17p)
will demand evaluation of thousands of models
(227–2 for a dichotomic trait), we focused in this
manuscript to describe results of the LPHN3–11q
interaction.
LPHN3–11q interaction
Single marker and haplotype case–control association
analysis revealed a single strongly associated
haplotype (rs677642–rs877137, G–G; OR=4.47, CI
2.30–8.69, P<0.000005, Pcorrected < 0.005; Figure 1a,
Table 1a). This haplotype spans 166 kbps from intron
7 of the gene coding neural cell adhesion molecule 1
(NCAM1), encompasses the tetratricopeptide repeat
domain 12 (TTC12) and the ankyrin repeat and kinase
domain containing 1 (ANKK1), and is adjacent to the
50 untranslated region of the dopamine receptor D2
(DRD2; Figure 1a). To avoid the potential effects of
genetic stratification, a known cause of type I error,
we performed a transmission disequilibrium test
analysis in the entire set of multigenerational, nuclear
and trio Paisa families. The OR for the transmission of
the susceptibility variants on 4q and 11q is 3.14 (95%
CI=1.49–6.62; P<0.0027) compared with transmis-
sion of neither variant (Table 1b). Both the association
analysis and the transmission disequilibrium test
demonstrate that the significance of the association
on chromosome 11q is lost when not conditioning
on the presence of the susceptibility variant within
LPHN3.
Looking for replication, we performed a transmis-
sion disequilibrium test analyses for three additional
samples: one from Germany and two primarily
European-American samples consisting of 95 trios
collected at the National Human Genome Research
Institute, Bethesda, MD, USA (US1) and 240 trios
from a sample collected at Children’s Hospital of
Philadelphia, Philadelphia, PA, USA (US2; Table 1b).
All these three samples were used for the replication
of the LPHN3 association to ADHD.8 The US2 sample
was not genotyped at identical SNPs on 11q, so we
tested two tag-SNPs that fully describe the variation
(r2 = 1, rs754672, rs965560) for the CEU sample (The
International HapMap Consortium, 2005; http://
hapmap.ncbi.nlm.nih.gov). Overall, all of these results
show a similar pattern of interaction and suggest that
the haplotype on 11q interacts cooperatively with
the LPHN3 susceptibility variant to increase the
risk to ADHD. A meta-analysis of the transmission
disequilibrium test results from the four samples,
using a random effects model, demonstrated a
significant association to the transmission of both
susceptibility variants on chromosome 4q and 11q
(OR=2.46, 95% CI=1.63–3.70, P<0.00001; Figure 1b
and Table 1c).
Effects of the LPHN3–11q interaction on brain
metabolism and ADHD
To define how the above described LPHN3–11q
interaction modulates the original effects of the
LPHN3 susceptibility variant on brain metabolism,
we next examined proton magnetic resonance spec-
troscopy (1H-MRS) data of 18 individuals from the
Paisa genetic isolate to four metabolites, namely, N-
acetylaspartate, myoinositol, choline and glutamine
(for all taken as the ratio to creatine), in several brain
regions making up part of the frontal–striatal–cere-
bellar circuit.
The full two-locus interaction model9,10 was fit to
the data by using linear regression, where y is the
quantitative MRS metabolite phenotype, m is the
mean effect, A is the age at diagnosis, S is a code for
gender (males = 0, females = 1), D describes disease
status (unaffected=0, affected=1), xi, i=1, 2, is a
variable modeling an additive effect (1 for homo-
zygote for allele 1, 0 for a heterozygote and 1 for a
homozygote for allele 2), zi is a dummy variable for a
dominant effect (0.5 for homozygote for allele 1, 0.5
for a heterozygote and 0.5 for a homozygote for
allele 2), ai and di refer to additive and dominant
coefficients estimated for the single locus effect, and
iaa, iad, ida and idd represent epistatic coefficients in the
following model:
y ¼ mþ SþAþ D þ a1x1 þ d1z1 þ a2x2 þ d2z2
þ iaax1x2 þ iadx1z2 þ idaz1x2 þ iddz1z2
This model was compared with a nested model
lacking interaction coefficients by a likelihood ratio
test (LRT) that follows a w2 distribution with four
degrees of freedom. Three regions gave results that
were significant after permutation (Ppermuted < 0.05).
They are myoinositol in the right posterior cingulate
gyrus, myoinositol in the left posterior cingulate
gyrus and choline in the right medial cingulate gyrus.
Examining the coefficients for each disclosed that for
myoinositol in the right and left posterior cingulate,
the iad coefficient for an interaction between an
additive effect from the haplotype on 11q and a
dominant effect from rs6551665 was contributing to
the better fitting model (iad left cingulate gyrus
P=0.00342; iad right cingulate gyrus P=0.00298).
Thus, the means were plotted for an additive effect
from the 11q haplotype and a dominant effect from
rs6551665 (where values from individuals that were
AA or AG at rs6551665 were grouped). The results
demonstrate that having two copies of the suscept-
ibility haplotype on chromosome 11 and GG at
rs6551665 correlates with a significant decrease in
myoinositol in the two regions (Figure 2a and b).
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Table 1 (a) Results of a case–control association analysis conditioning on individuals with the susceptibility variant within
LPHN3 (P<0.000005, Pcorrected < 0.005), with 48 affected cases and 39 unaffected controls; (b) results of a TDT analysis in trios
derived from nuclear families from the Paisa genetic isolate, Germany and two primarily European American samples (USA1—
National Human Genome Research Institute, Bethesda, MD, USA; USA2—Children’s Hospital of Philadelphia, Philadelphia, PA,
USA); (c) results of the fixed-effect meta-analysis on the four samples
(a)a
LPHN3b 11q haplotypec Cases (frequency,
%)
Controls
(frequency, %)
OR (95% CI) P-value
G GG 55 (57) 18 (23) 4.47 (2.30, 8.69) P<0.000005,
G Else 41 (43) 60 (77) Pcorrected < 0.005
(b)d
Sample LPHN3b 11q haplotypee Transmitted
(frequency, %)
Not transmitted
(frequency, %)
OR (95% CI) P-value
Paisa G GG 31 (10.2) 10 (3.3) 3.14 (1.49, 6.62) 0.0027
G Else 39 (12.9) 27 (8.9) 1.46 (0.85, 2.51) 0.1661
Else GG 78 (25.7) 108 (35.8) 0.73 (0.51, 1.06) 0.0943
Else Else 155 (51.2) 157 (52) Reference Reference
German G GG 26 (7.9) 13 (3.9) 1.91 (0.95, 3.84) 0.0706
G Else 58 (17.6) 50 (15.2) 1.11 (0.72, 1.71) 0.6505
Else GG 75 (22.7) 104 (31.5) 0.69 (0.48, 0.99) 0.0449
Else Else 171 (51.8) 163 (49.4) Reference Reference
US1 G GG 9 (7.9) 3 (2.6) 3.1 (0.8, 12) 0.1014
G Else 19 (16.7) 16 (13.9) 1.23 (0.58, 2.59) 0.5955
Else GG 23 (20.2) 31 (27) 0.77 (0.4, 1.45) 0.4139
Else Else 63 (55.3) 65 (56.5) Reference Reference
US2 G AG 22 (5.7) 9 (2.4) 2.28 (1.03, 5.08) 0.0432
G Else 108 (28.4) 123 (32.4) 0.82 (0.59, 1.13) 0.2279
Else AG 40 (10.5) 52 (13.7) 0.72 (0.46, 1.13) 0.1306
Else Else 210 (55.3) 196 (51.6) Reference Reference
(c)
Meta-analysis OR (95% CI) P-value
Interaction 2.46 (1.68, 3.70) < 0.00001
LPHN3 onlyb 1.04 (0.86, 1.25) 0.7111
Haplotype onlye 0.73 (0.61, 0.87) < 0.001
Abbreviations: CI, confidence interval; OR, odds ratio; TDT, transmission disequilibrium test.
aDemonstrates an OR of 4.47 (2.30–8.69) for having both susceptibility variants compared with the variant within LPHN3 itself.
bDefined by the marker rs6551665 in chromosome 4.
cDefined by the markers rs677642 and rs877137 in chromosome 11.
dFor the Paisa sample the OR for the transmission of the susceptibility variants on 4q and 11q is 3.14 (95% CI=1.49–6.62)
compared with transmission of neither variant, 2.15 (95% CI=0.9–5.1) compared with transmission solely of the susceptibility
variant on 4q and 4.3 (95% CI=2.0–9.3) compared with the sole transmission of the susceptibility variant on 11q. For the German
sample, the OR for the transmission of the susceptibility variants on 4q and 11q is 1.91 (95% CI=0.95–3.84) compared with
transmission of neither variant, 1.72 (95% CI=0.80–3.71) compared with transmission solely of the susceptibility variant on 4q
and 2.78 (95% CI=1.34–5.75) compared with the sole transmission of the susceptibility variant on 11q. For the USA1 sample, the
OR for the transmission of the susceptibility variants followed the same trend as the other samples where on 4q and 11q, it is 3.10
(0.80–12) compared with transmission of neither variant, 2.53 (95% CI=0.58–10.95) compared with transmission solely of the
susceptibility variant on 4q and 4.04 (95% CI=0.98–16.62) compared with the sole transmission of the susceptibility variant on
11q. For the USA2 sample, we see over-transmission of the susceptibility variants (P<0.04). The OR for variants on 4q and 11q is
2.28 (95% CI=1.03–5.08) compared with neither variant transmitted, 2.78 (95% CI=1.2–6.3) compared with transmission of only
the susceptibility variant on 4q and 3.2 (95% CI=1.3–7.6) compared with transmission of only the susceptibility variant on 11q.
eDefined by the markers rs677642 and rs877137 in chromosome 11 except in the US2 sample, for which it is defined by the
markers rs754672 and rs965560.
Note: TDT results after a combination of 4q–11q variants originates a definitive decrease of the original sample size, reported
by Arcos-Burgos et al. (2010). The decrease of the sample size occurs as a consequence of the ad hoc strategy of conditioning
on the fact of being a carrier of the G variant of susceptibility at rs6551665. Furthermore, because of genotype limitations, the
Norwegian and Spaniard samples were not genotyped for markers in 11q, and given that TDT was selected to evaluate
interaction effects, much information contained in the original family structure sample was lost.
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The results for choline in the right medial cingulate
demonstrated that the iad coefficient for an interaction
between an additive effect from rs6551665 and a
dominant effect from the 11q haplotype was con-
tributing to the better fitting model (P=0.00968). The
results were plotted for an additive effect from
rs6551665 and a dominant effect from the haplotype
on 11q (where having one or two copies of the
susceptibility haplotype were grouped). The results
demonstrate that having AG at rs6551665 and at least
one copy of the susceptibility haplotype on 11q is
related to an increase in choline in the right medial
cingulate and that having AG at rs6551665 and no
copies of the susceptibility haplotype on 11q is
related to a decreased level of choline in the right
medial cingulate region (Figure 2c).
Effects of the LPHN3–11q interaction on ADHD
pharmacogenetics
We next attempted to study the effect of the
LPHN3–11q interaction with regards to the pharma-
cogenetic consequences that the LPHN3 ADHD-
susceptibility variant had on the treatment response
to stimulant medication. In all, 82 individuals with
complete genotype and phenotype information
from the US1 sample were included in the analysis.
Figure 2 (a) Fitting of myoinositol/creatinine levels in the right posterior cingulated gyrus resulted in a significant
improvement when modeled with a two-loci model compared to a single, main-effects model (Ppermuted < 0.05). (b) Fitting of
myoinositol/creatinine levels in left posterior cingulate gyrus resulted in a significant improvement when modeled with a
two-loci model compared with a single, main-effects model (Ppermuted < 0.05). (c) Fitting of choline/creatinine levels in the
right medial cingulate gyrus resulted in a significant improvement when modeled with a two-loci model compared with a
single, main-effects model (Ppermuted < 0.05). (d) Results for question 18 on the SWAN scale (hyperactive question; ‘butting
into conversations’) and response to methylphenidate demonstrates significant two locus model effect compared with single
locus effects (Ppermuted=0.0036). In all, 82 individuals from the USA1 sample were included. The y-axis represents
improvement in the symptom after taking stimulant medication. The iad coefficient for an interaction between an additive
effect from chromosome 4 and a dominant effect from chromosome 11 indicated the better fitting model (P=0.027).
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These individuals were sampled from the original 240
individual sample described by our group with
complete demographic information of this sample
presented in the Supplementary Information.8 In
addition, comparative analyses regarding stimulant
treatment have been also presented.8 Then we
examined the relationship of SWAN scale questions
individually as well as inattentive and hyperactive
combined dimensions (questions 1–9 indicate inat-
tentive symptoms and questions 10–18 indicate
hyperactive symptoms before and after starting
methylphenidate medication). We observed a signifi-
cantly better fitting model for question 18 (hyperac-
tive–impulsive dimension) when the iad coefficient
for interaction between additive effects at LPHN3 and
dominant effects at 11q are included (Pcor-
rected = 0.0036). Overall results demonstrate that hav-
ing GG at rs6551665 and two copies of the
susceptibility haplotype on 11q is correlated with a
significant improvement of symptoms after the treat-
ment with stimulant medication, and that having AA
at rs6551665 and fewer than two copies of the
susceptibility haplotype on 11q is correlated with a
poor response to stimulant medication treatment
(Figure 2d).
Although statistically significant, the importance of
the genetic LPHN3–11q interaction regarding the
treatment response to stimulant medication requires
larger studies to both replicate and assess the
contribution of this interaction to ADHD symptoms
and response to stimulant medication.
Discussion
Variants within LPHN3were recently demonstrated to
be associated with ADHD in samples derived from
various populations.8 The demonstrated OR wasB1.2
(95% CI=1.09–1.38, P<5.42 104) for having ADHD
in individuals carrying susceptibility variants within
LPHN3. In this analysis, when rs6551665 within
LPHN3 is examined concomitantly with the haplo-
type on 11q the OR is 2.46 (95% CI=1.68–3.70,
P<0.00001). The haplotype on 11q by itself does not
exhibit main effects. However, the association with
ADHD is demonstrated when conditioning on the
susceptibility variant within LPHN3. Thus, the
haplotype on 11q seems to function as a modifier of
LPHN3 susceptibility.
The haplotype on chromosome 11q spans 166 kbps,
from intron 7 of NCAM1, encompasses TTC12 and
ANKK1 and is adjacent to DRD2. There is evidence
that variation in this region is associated with human
behavior. SNPs and haplotypes across this identical
region were previously demonstrated to be associated
with nicotine, alcohol and drug dependence.
Strongest signals were located within TTC12 and/or
ANKK1.11–13 The function of TTC12 is not well
described, although expression has been reported in
testis, prostate, lung, lymphocytes and numerous
tumors.14,15 Although there are conflicting results
for replication, DRD2 is a putative candidate
gene for ADHD given its involvement in dopamine
metabolism.16 Of note, the commonly tested poly-
morphism DRD2 Taq1A was found to be within exon
8 of ANKK1, where it causes a glutamine to lysine
amino acid change.17 ANKK1 was found to be
expressed in placenta and spinal cord but to date
has not been observed in the developing or adult
brain.17 NCAM1 is a member of the immunoglobin
superfamily and is thought to have a fundamental role
in normal neural development, function and plasti-
city.18,19 Mouse knockout models of NCAM1 have
been described to mimic schizophrenia based on
brain morphological changes as well as reduced
prepulse inhibition of the startle response.20,21
Furthermore, NCAM1 mouse models have also been
demonstrated to have hyperactivity, aggression, anxi-
ety and abnormal social behaviors.22 In humans,
genetic variation has been suggested to be associated
with neural tube defects and bipolar disorder.23,24
Isoform variation in postmortem brain and cerebrosp-
inal fluid has been described to be associated with
schizophrenia, bipolar disorder and autism, suggest-
ing NCAM1 has many pleiotropic effects.25 Although
we have genetic evidence for locus interaction in the
development of ADHD, the specific biological me-
chanism and gene products are not clear. Character-
ization of homeostatic and pathophysiological
mechanisms of gene products on 11q and LPHN3
are necessary in order to determine the precise
mechanistic interaction and any discussion of the
mechanism until then is purely speculative.
The fact that the LPHN3–11q interaction better
describes the proton MRS metabolite differences in
the cingulate gyrus, with the strongest findings
demonstrated for myoinositol in the posterior cingu-
late gyrus, might be compatible with recent findings
of gray matter volume reduction in ADHD patients in
the posterior cingulate26 and with reduced activation
of the posterior cingulate gyrus detected by functional
magnetic resonance imaging in ADHD patients during
sustained tasks and inhibition failure.27 Overall this
region is hypothesized to be important for the inter-
play of attention and motivation and in particular
visuospatial attention. It is worth mentioning that the
main difference regarding 1H-MRS data between this
report and the original report of Arcos-Burgos et al.4 is
that additional brain metabolites were known at the
time of the making of this report. Analyses of
association of one locus marker data to 1H-MRS data
are part of a different manuscript that is currently
prepared for submission. Evaluation of 1H-MRS data
in the context of two-locus interaction had the main
goal to show that the two-locus interaction was able of
predict genetic effects on brain metabolism much
better than a model of one-locus.
As exemplified by the few reproducible genes
discovered to date for ADHD, there are numerous
difficulties that must be overcome in mapping
disorders that are thought to have complex origins,
including low penetrance, heterogeneity, pleiotropy
and epistasis. Assaying and accounting for these
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potential complexities are of extreme importance
when searching for the specific genetic variations
that underlie disease susceptibility. In this case,
accounting for epistasis disclosed a variant that
would have been missed by traditional association
analysis. In summary, we demonstrate that an inter-
action between rs6551665 within LPHN3 and a region
on chromosome 11q is involved in ADHD suscept-
ibility and substantially increases the OR for having
ADHD compared to examining the LPHN3 common
variant associated with ADHD on its own.
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